Michael O’Callaghan

2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans

Richard K. Wilson, R. Ainscough, Kimberly Anderson et al. · Nature · 1994 · 1.5K citations

Life Sciences, Genetics, Molecular Genetics +10

A Phase 1/2 Clinical Trial of Enzyme Replacement in Fabry Disease: Pharmacokinetic, Substrate Clearance, and Safety Studies

Christine M. Eng, Maryam Banikazemi, Ronald E. Gordon et al. · The American Journal of Human Genetics · 2001 · 383 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10

Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy

G. McMichael, Matthew N. Bainbridge, Eric Haan et al. · Molecular Psychiatry · 2015 · 238 citations

Life Sciences, Genetics, Molecular Genetics +14

Epidemiologic Associations With Cerebral Palsy

Michael O’Callaghan, Alastair H. MacLennan, Catherine Gibson et al. · Obstetrics and Gynecology · 2011 · 123 citations

Public Health, Maternal Health, Obstetrics +14

BNC105: A Novel Tubulin Polymerization Inhibitor That Selectively Disrupts Tumor Vasculature and Displays Single-Agent Antitumor Efficacy

Gabriel Kremmidiotis, Annabell F. Leske, Tina C. Lavranos et al. · Molecular Cancer Therapeutics · 2010 · 76 citations

Medicine, Oncology, Pharmacology +15